Observable data points shared across all narratives
If the committee dispute undermines confidence in NCDC oversight or delays health policy decisions, investor sentiment toward Nigerian healthcare and diagnostics stocks could become more volatile.
The chairman of the Nigerian Senate Committee overseeing the Nigeria Centre for Disease Control (NCDC), Senator Ibrahim Oloriegbe Zam, has publicly stated that Senator Natasha Akpoti-Uduaghan is not a member of the NCDC-related committee and was never invited to its sessions, accusing her of misunderstanding the committee’s work. The clarification follows public comments by Senator Natasha that prompted a rebuttal from the committee leadership, highlighting internal tensions within the Senate over committee roles and public communication. This dispute unfolds as Senator Natasha is also visible in other health and religious affairs debates, including her support for President Bola Tinubu’s nominee Jalal Arabi Yusuf as NAHCON chair.
This is not investment advice. Market exposure is based on conditional event analysis.